European Medical Journal » Nephrology
317 FOLLOWERS
The European Medical Journal is a specialist publisher who combines leading editorials from key opinion leaders with a concise news coverage from the leading congresses within the industry, delivering world-class insights to the key developments and advancements within both clinical and pharmaceutical areas.
European Medical Journal » Nephrology
6d ago
Chronic Active Antibody-mediated Rejection in Renal Transplant Recipients In 2022, over 92,000 kidney transplants were performed globally.1 With advancements in transplant science, 1-year graft survival rates ..read more
European Medical Journal » Nephrology
3w ago
Smeeta Sinha National Clinical Director for Renal Medicine, NHS England, UK; Consultant Nephrologist, Northern Care Alliance NHS Foundation ..read more
European Medical Journal » Nephrology
3w ago
End-stage liver disease (ESLD) represents a non-reversible, advanced stage of cirrhosis, where the hepatic architecture is distorted and ..read more
European Medical Journal » Nephrology
3w ago
Sparsentan for treatment of immunoglobulin A nephropathy: Latest study results In patients with immunoglobulin A nephropathy, use of the endothelin 1 Type A/Ang II subtype 1 receptor antagonist sparsentan can decrease proteinuria and preserve kidney function ..read more
European Medical Journal » Nephrology
1M ago
Membranous Nephropathy and Pulmonary Tuberculosis: An Uncommon Combination: Case Report Mycobacterium tuberculosis causing glomerulonephritis (GN) is a rare occurrence, and its association has been seldom reported ..read more
European Medical Journal » Nephrology
4M ago
Current Treatment and Emerging Solutions in IgA Nephropathy IgAN, which can lead to CKD and kidney failure, is the most common form of primary glomerulonephritis, predominantly ..read more
European Medical Journal » Nephrology
8M ago
Diagnosing Fabry Disease: Practical Clinical Recommendations and Guidance for Patients with Fabry Disease This article was funded by Sanofi and is intended for healthcare professionals ..read more
European Medical Journal » Nephrology
9M ago
Recent Advances in Targeting Complement in Glomerular Disease The complement system has been an appealing drug target for a long time. However, early drug development efforts have failed for ..read more
European Medical Journal » Nephrology
9M ago
I only ever wanted to be a paediatrician, thanks to ER’s Doug Ross, and my first job was on the nephrology service in Temple Street ..read more
European Medical Journal » Nephrology
9M ago
Proteinuria as a Surrogate Endpoint for Disease Progression in IgA Nephropathy: Predicting Long-Term Treatment Effects of Sparsentan IgA nephropathy (IgAN) is a rare, life-limiting disease for which there is significant unmet need. Until recently, drug development for ..read more